創新醫療(002173.SZ):建華醫院與寶信國際融資租賃糾紛達成和解
格隆匯12月16日丨創新醫療(002173.SZ)公佈,公司於2021年12月15日召開的第五屆董事會2021年第三次臨時會議,審議通過了《關於同意建華醫院與寶信國際就(2021)陝民終451號<民事判決書>簽署<和解協議>的議案》、《關於同意建華醫院與寶信國際就(2021)陝民終428號<民事判決書>簽署<和解協議>的議案》。
鑑於公司子公司齊齊哈爾建華醫院有限責任公司(簡稱“建華醫院”)與寶信國際融資租賃有限公司(簡稱“寶信國際”)、北京遠程視界醫院管理有限公司的融資租賃合同糾紛案和建華醫院與寶信國際、北京遠程中衞婦科醫院管理有限公司的融資租賃合同糾紛案已經陝西省高級人民法院作出終審判決,為了減少損失、避免強制執行對建華醫院經營管理帶來負面影響,公司董事會同意建華醫院與寶信國際就上述融資租賃交易糾紛事項分別簽署《和解協議》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.